Clinical trial
CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas
NCT00185965 · Ronald Levy, Other · Completed
Key facts
| NCT number | NCT00185965 |
|---|---|
| Title | CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas |
| Official title | Le23 CPG: A Phase 1-2 Study of Intratumoral Injection of CPG 7909, A TLR 9 Agonist, Combined With Local Radiation in Recurrent Low-Grade Lymphomas |
| Lead sponsor | Ronald Levy, Other |
| Collaborators | Lymphoma Research Foundation American Society of Clinical Oncology |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin Lymphoma, Mycosis Fungoides |
| Intervention type | Drug |
| Interventions | CPG 7909 |
| Enrollment | 30 |
| Start date | Jul 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 1, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: